Although the relation between miR-195-5p/497–5p and MCM2 in colon cancer has rarely been studied before, MCM2 has been reported to be targeted by miR-31 in nasopharyngeal carcinoma and prostate cancer [21, 22]. This evidence concerns the gene MCM2 and prostate cancer.